Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep for people with obstructive apnea. | Resmed believes ...

Resmed (NYSE: RMD) announced today that it received FDA clearance for its Smart Comfort personalized therapy comfort settings ...

Technology uses real-world sleep data and machine learning to help people with sleep apnea start and stay on therapy ...

Resmed has received clearance from the U.S. Food and Drug Administration (FDA) for an artificial intelligence (AI)-enabled ...

GLP-1 drugs pose an existential threat to CPAP-makers. ResMed is currently experiencing temporary tailwinds before potential long-term headwinds. ResMed (NYSE: RMD) finds itself in an investment limbo ...

Resmed gains FDA's nod for Smart Comfort, an AI-driven CPAP tool boosting sleep therapy personalization and adherence.

ResMed’s market performance aligns with the S&P 500 index Expanding global reach through advanced healthcare solutions ...

Air Voel, one of Canada’s leading providers of CPAP machines, masks, and sleep-health solutions, today announced the launch of its Sleep Better 2026 Initiative, a nationwide program designed to raise ...

ResMed has secured FDA clearance for its Personalized Therapy Comfort Settings (PTCS), branded as Smart Comfort - a ...

A pioneering study, led by PFL Healthcare in collaboration with the University of Sheffield, has demonstrated that ...